Clinical question: How effective and safe are apixaban versus rivaroxaban versus warfarin in patients with cirrhosis and nonvalvular atrial fibrillation (AF)? Background: Apixaban, rivaroxaban, and ...

Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

Medication for AFib focuses on controlling heart rate, controlling heart rhythm, or preventing blood clots. Share on Pinterest Marc Tran/Stocksy United Atrial fibrillation (AFib) is the most commo ...

Rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack (TIA) in patients younger than 65 with nonvalvular atrial fibrillation (AFib) and low risk for stroke ...

Clinical question: How effective and safe are apixaban versus rivaroxaban versus warfarin in patients with cirrhosis and nonvalvular atrial fibrillation (AF)? Background: Apixaban, rivaroxaban, and ...

A recent study published in JAMA has raised concerns about the safety of certain blood pressure medications for patients with ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation ... Factor Xa inhibitor Eliquis (apixaban) in AF patients at ...

Younger patients with the common heart rhythm disorder atrial fibrillation but no other risk factors for stroke are not likely ... Half of them received 15 milligrams daily of rivaroxaban, sold by ...

Younger patients with the common heart rhythm disorder atrial fibrillation but no other risk ... (JNJ.N), opens new tab under the brand name Xarelto. The others received a placebo.